We are live on
!
Find out more
FCOMV
Foresite Capital Opportunity Management V Portfolio holdings
AUM
$33.3M
1-Year Est. Return
47.04%
This Fund
S&P 500
This Quarter
Est. Return
-43.82%
1 Year Est. Return
-47.04%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.4M
AUM Growth
-$77.7M
(-52%)
Cap. Flow
-$7.21M
Cap. Flow
% of AUM
-10.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Enanta Pharmaceuticals
ENTA
|
+$1.48M |
Top Sells
| 1 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
+$8.01M |
| 2 |
Cullinan Oncology
CGEM
|
+$678K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $37.7M | 52.85% |
5,227,307
| – | – |
|
2
Quantum-Si Incorporated
QSI
$189M
| $7.48M | 10.47% |
1,598,125
| – | – |
|
|
THRX
3
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.41M | 7.57% |
468,820
| – | – |
|
|
HLTH
4
DELISTED
Cue Health Inc. Common Stock
HLTH
| $4.14M | 5.79% |
641,483
-885,620
| -58% | -$8.01M |
|
|
5
Cullinan Oncology
CGEM
$1.1B
| $3.46M | 4.85% |
330,836
-50,166
| -13% | -$678K |
|
6
Adicet Bio
ACET
$79.9M
| $3.4M | 4.75% |
10,625
| – | – |
|
7
Disc Medicine
IRON
$2.9B
| $3.38M | 4.74% |
81,171
| – | – |
|
|
KNTE
8
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.28M | 4.6% |
291,667
| – | – |
|
|
9
Enanta Pharmaceuticals
ENTA
$397M
| $1.62M | 2.27% |
+22,750
| New | +$1.48M |
|
10
Compass Therapeutics
CMPX
$407M
| $1.51M | 2.11% |
1,100,000
| – | – |
|
Similar funds
SHI
SAM
LUGPSI
KXA
PGM
ACM
KCM
ALFIA